ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/04/24 | 3,345 | 3,375 | 3,300 | 3,350 | ±0 | ±0% | 1,036,400 |
2017/04/21 | 3,370 | 3,425 | 3,335 | 3,350 | -35 | -1% | 1,102,400 |
2017/04/20 | 3,360 | 3,470 | 3,290 | 3,385 | +40 | +1.2% | 2,379,000 |
2017/04/19 | 3,335 | 3,415 | 3,330 | 3,345 | -25 | -0.7% | 1,659,600 |
2017/04/18 | 3,455 | 3,455 | 3,315 | 3,370 | -55 | -1.6% | 2,616,800 |
2017/04/17 | 3,235 | 3,430 | 3,220 | 3,425 | +230 | +7.2% | 3,723,800 |
2017/04/14 | 3,200 | 3,265 | 3,150 | 3,195 | -35 | -1.1% | 3,309,800 |
2017/04/13 | 2,965 | 3,250 | 2,960 | 3,230 | +260 | +8.8% | 4,458,600 |
2017/04/12 | 2,950 | 3,020 | 2,930 | 2,970 | -75 | -2.5% | 2,991,000 |
2017/04/11 | 3,100 | 3,135 | 2,980 | 3,045 | -80 | -2.6% | 7,870,600 |
2017/04/10 | 3,075 | 3,125 | 3,060 | 3,125 | +500 | +19% | 5,420,200 |
2017/04/07 | 2,625 | 2,655 | 2,585 | 2,625 | +25 | +1% | 1,141,200 |
2017/04/06 | 2,605 | 2,610 | 2,550 | 2,600 | -15 | -0.6% | 1,139,800 |
2017/04/05 | 2,605 | 2,625 | 2,580 | 2,615 | +15 | +0.6% | 996,800 |
2017/04/04 | 2,640 | 2,650 | 2,560 | 2,600 | -60 | -2.3% | 1,237,400 |
2017/04/03 | 2,670 | 2,695 | 2,635 | 2,660 | +35 | +1.3% | 839,200 |
2017/03/31 | 2,655 | 2,665 | 2,625 | 2,625 | -15 | -0.6% | 752,200 |
2017/03/30 | 2,735 | 2,745 | 2,625 | 2,640 | -105 | -3.8% | 1,228,000 |
2017/03/29 | 2,750 | 2,780 | 2,735 | 2,745 | +25 | +0.9% | 919,800 |
2017/03/28 | 2,690 | 2,725 | 2,665 | 2,720 | +80 | +3% | 993,600 |
2017/03/27 | 2,655 | 2,700 | 2,635 | 2,640 | -5 | -0.2% | 716,600 |
2017/03/24 | 2,645 | 2,665 | 2,625 | 2,645 | ±0 | ±0% | 551,200 |
2017/03/23 | 2,645 | 2,650 | 2,610 | 2,645 | -10 | -0.4% | 791,200 |
2017/03/22 | 2,635 | 2,675 | 2,630 | 2,655 | -25 | -0.9% | 573,000 |
2017/03/21 | 2,670 | 2,705 | 2,670 | 2,680 | -15 | -0.6% | 557,000 |
2017/03/17 | 2,740 | 2,745 | 2,670 | 2,695 | -55 | -2% | 830,800 |
2017/03/16 | 2,710 | 2,760 | 2,705 | 2,750 | +40 | +1.5% | 604,800 |
2017/03/15 | 2,785 | 2,800 | 2,665 | 2,710 | -95 | -3.4% | 1,468,800 |
2017/03/14 | 2,840 | 2,840 | 2,785 | 2,805 | -45 | -1.6% | 947,200 |
2017/03/13 | 2,885 | 2,905 | 2,845 | 2,850 | -30 | -1% | 991,800 |
2017/03/10 | 2,835 | 2,885 | 2,830 | 2,880 | +65 | +2.3% | 1,032,000 |
2017/03/09 | 2,785 | 2,825 | 2,780 | 2,815 | +35 | +1.3% | 906,200 |
2017/03/08 | 2,755 | 2,790 | 2,750 | 2,780 | +5 | +0.2% | 939,000 |
2017/03/07 | 2,780 | 2,785 | 2,740 | 2,775 | -10 | -0.4% | 802,600 |
2017/03/06 | 2,765 | 2,805 | 2,765 | 2,785 | +20 | +0.7% | 928,000 |
2017/03/03 | 2,750 | 2,790 | 2,750 | 2,765 | +30 | +1.1% | 1,052,000 |
2017/03/02 | 2,775 | 2,775 | 2,715 | 2,735 | -15 | -0.5% | 1,121,000 |
2017/03/01 | 2,700 | 2,755 | 2,685 | 2,750 | +85 | +3.2% | 1,267,800 |
2017/02/28 | 2,700 | 2,740 | 2,655 | 2,665 | -10 | -0.4% | 1,323,200 |
2017/02/27 | 2,625 | 2,700 | 2,615 | 2,675 | +40 | +1.5% | 1,340,800 |
2017/02/24 | 2,650 | 2,675 | 2,605 | 2,635 | -20 | -0.8% | 1,080,400 |
2017/02/23 | 2,600 | 2,655 | 2,580 | 2,655 | +55 | +2.1% | 1,119,200 |
2017/02/22 | 2,640 | 2,645 | 2,570 | 2,600 | -10 | -0.4% | 1,075,600 |
2017/02/21 | 2,650 | 2,650 | 2,570 | 2,610 | -55 | -2.1% | 1,669,800 |
2017/02/20 | 2,685 | 2,695 | 2,645 | 2,665 | -35 | -1.3% | 874,200 |
2017/02/17 | 2,680 | 2,725 | 2,640 | 2,700 | -10 | -0.4% | 1,004,800 |
2017/02/16 | 2,765 | 2,785 | 2,700 | 2,710 | -55 | -2% | 1,163,400 |
2017/02/15 | 2,885 | 2,885 | 2,735 | 2,765 | -75 | -2.6% | 1,837,200 |
2017/02/14 | 2,890 | 2,895 | 2,835 | 2,840 | -45 | -1.6% | 645,400 |
2017/02/13 | 2,920 | 2,925 | 2,855 | 2,885 | ±0 | ±0% | 633,600 |
1951~
2000
件表示中 / 2898件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,000円 | +5.0% | +1.5% | 0.00% | 16.05倍 | 4.27倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 196,000円 | +4.0% | +25.4% | 2.70% | 8.57倍 | 1.12倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 362,200円 | +7.9% | +8.9% | 3.42% | 7.75倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 371,000円 | +14.5% | -2.3% | 2.43% | 13.57倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム